Abstract
To describe which providers provide breast cancer survivorship care, we conducted a longitudinal survey of nonmetastatic breast cancer patients identified by the SEER registries of Los Angeles and Detroit. Multinomial logistic regression examined the adjusted odds of surgeon compared with a medical oncologist follow-up or primary care provider compared with medical oncologist follow-up, adjusting for age, race/ethnicity, insurance, tumor stage, receipt of chemotherapy, endocrine therapy use, and visit to a medical oncologist at the time of diagnosis. Results were weighted to account for sample selection and nonresponse. 844 women had invasive disease and received chemotherapy or endocrine therapy. 65.2 % reported medical oncologists as their main care provider at 4 years, followed by PCP/other physicians (24.3 %) and surgeons (10.5 %). Black women were more likely to receive their follow-up care from surgeons (OR 2.47, 95 % CI 1.16–5.27) or PCP/other physicians (OR 2.62, 95 % CI 1.47–4.65) than medical oncologists. Latinas were more likely to report PCP/other physician follow-up than medical oncologists (OR 2.33, 95 % CI 1.15–4.73). Compared with privately insured women, Medicaid recipients were more likely to report PCP/other physician follow-up (OR 2.52, 95 % CI 1.24–5.15). Women taking endocrine therapy 4 years after diagnosis were less likely to report surgeons or PCP/other physicians as their primary provider of breast cancer follow-up care. Different survivorship care patterns emerge on race/ethnicity and insurance status. Interventions are needed to inform patients and providers on the recommended sources of breast cancer follow-up.
Similar content being viewed by others
References
Levit L, Balogh E, Nass S, et al (2013) Committee on Improving the Quality of Cancer Care. Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. National Academies Press, Washington DC
Siegel R, Naishadham D, Jemal A (2013) Cancer statistics. CA Cancer J Clin 63(1):11–30
Erikson C, Salsberg E, Forte G, Bruinooge S, Goldstein M (2007) Future supply and demand for oncologists: challenges to assuring access to oncology services. J Oncol Pract 3:79–86
Warren JL, Mariotto AB, Meekins A, Topor M, Brown ML (2008) Current and future utilization of services from medical oncologists. J Clin Oncol 26:3242–3247
Salsberg E, Grover A (2006) Physician workforce shortages: implications and issues for academic health centers and policymakers. Acad Med 81:782–787
Starfield B, Fryer GE Jr (2007) The primary care physician workforce: ethical and policy implications. Ann Farm Med 5:486–491
Arora NK, Reeve BB, Hays RD, Clauser SB, Oakley-Girvan I (2011) Assessment of quality of cancer-related follow-up care from the cancer survivor’s perspective. J Clin Oncol 29(10):1280–1289
Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE (2003) Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 21(22):4184–4193
Carver JR, Shapiro CL, Ng A et al (2007) American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 25(25):3991–4008
Camp-Sorrell D (2006) Cardiorespiratory effects in cancer survivors. Cancer Nurs 29(2 Suppl):55–59
McCabe MS, Bhatia S, Oeffinger KC et al (2013) American society of clinical oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol 31(5):631–640
Cheung WY, Aziz N, Noone AM et al (2013) Physician preferences and attitudes regarding different models of survivorship care: a comparison of primary care providers and oncologists. J Cancer Surviv 7(3):343–354
Klabunde CN, Han PK, Earle CC et al (2013) Physician roles in the cancer-related follow-up care of cancer survivors. Fam Med 45(7):463–474
Parmeshwar R, Margenthaler JA, Allam E et al (2013) Patient surveillance after initial breast cancer therapy: variation by physician specialty. Am J Surg 206(2):218–222
Mayer DK, Gerstel A, Leak AN, Smith SK (2012) Patient and provider preferences for survivorship care plans. J Oncol Pract 8(4):e80–e86
Potosky AL, Han PK, Rowland J et al (2011) Differences between primary care physicians’ and oncologists’ knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med 26(12):1403–1410
Griggs JJ, Hawley ST, Graff JJ et al (2012) Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample. J Clin Oncol 30(25):3058–3064
Janz NK, Mujahid MS, Hawley ST et al (2009) Racial/ethnic differences in quality of life after diagnosis of breast cancer. J Cancer Surviv 3(4):212–222
Dillman DA (2007) Mail Internet Surveys: the tailored design method, 2nd edn. Wiley, New York
Burstein HJ, Prestrud AA, Seidenfeld J et al (2010) American society of clinical oncology clinical practice guideline: update on adjuvant endocrine therapy for women with endocrine receptor-positive breast cancer. J Clin Oncol 28(23):3784–3796
Davies C, Hongchao P, Godwin J et al (2013) Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381(9869):805–816
Jin H, Tu D, Zhao N et al (2012) Longer-term outcomes of Letrozole versus placebo after 5 years of tamoxifen in the NCIC CTG MA.17 trial: analyses adjusting for treatment crossover. J Clin Oncol 30(7):718–721
Weaver KE, Camacho F, Hwang W, Anderson R, Kimmick G (2012) Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income women. Am J Clin Oncol 36(2):181–187
Hershman DL, Shao T, Kushi LH et al (2011) Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 126:529–537
Hershman DL, Kushi LH, Shao T et al (2010) Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol 28(27):4120–4128
Partridge AH, Lafountain A, Mayer E et al (2008) Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 26:556–562
Friese CR, Pini TM, Abrahamse PH et al (2013) Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer. Breast Cancer Res Treat 138(3):931–939
Atkins L, Fallowfield L (2006) Intentional and non-intentional non-adherence to medication amongst breast cancer patients. Eur J Cancer 42:2271–2276
Demissie S, Silliman RA, Lash TL (2001) Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J Clin Oncol 19:322–328
Fink AK, Gurwitz J, Rakowski W, Guadagnoli E, Silliman RA (2004) Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. J Oncol Pract 8(6):e149–e157
Aiello Bowles EJ, Boudreau DM, Chubak J et al (2012) Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer. J Oncol Pract 8(6):e149–e157
Kahn KL, Schneider EC, Malin JL, Adams JL, Epstein AM (2007) Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use. Med Care 45:431–439
Snyder CF, Frick KD, Kantsiper ME et al (2009) Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol 27(7):1054–1061
Snyder CF, Frick KD, Peairs KS et al (2009) Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med 24(4):469–474
Earle CC, Ganz PA (2012) Cancer survivorship care: don’t let the perfect be the enemy of the good. J Clin Oncol 20(30):3764–3768
Hewitt M, Greenfield S, Stovall E (2005) From cancer patient to cancer survivor: Lost in transition. National Academies Press, Washington
Kantsiper M, McDonald EL, Geller G et al (2009) Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med 24(Suppl 2):459–466
Grunfeld E, Julian JA, Pond G et al (2011) Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol 29(36):4755–4762
Del Guidice ME, Grunfeld E, Harvey BJ, Piliotis E, Verma S (2009) Primary care physicians’ views of routine follow-up care of cancer survivors. J Clin Oncol 27:3338–3345
Acknowledgments
This study was supported by Grants R01 CA109696 and R01 CA088370 from the National Cancer Institute (NCI) to the University of Michigan. Dr. Friese was supported by a pathway to independence award from the National Institute for Nursing Research (R00NR01570). Dr. Jagsi was supported by a mentored research scholar grant from the American Cancer Society (MRSG-09-145-01). Dr. Katz was supported by an established investigator award in cancer prevention, control, behavioral, and population sciences research from the NCI (K05CA111340). The collection of LA County cancer incidence data used was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the NCI’s SEER program under contract N01-PC-35139 awarded to the University of Southern California, contract N01-PC-54404 awarded to the Public Health Institute; and the Centers for Disease Control and Prevention’s National Program of Cancer registries, under agreement 1U58DP00807-01 awarded to the Public Health Institute. The collection of metropolitan Detroit cancer incidence data was supported by the NCI SEER Program contract N01-PC-35145.
Conflict of interest
The authors declare they have no conflict of interest.
Ethical standards
The study complied with the ethical standards set forth for human subjects by the University of Michigan, Detroit, and California sites.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Friese, C.R., Martinez, K.A., Abrahamse, P. et al. Providers of follow-up care in a population-based sample of breast cancer survivors. Breast Cancer Res Treat 144, 179–184 (2014). https://doi.org/10.1007/s10549-014-2851-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-014-2851-8